Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Polio vaccine new sequential schedule to be discussed by ACIP at Feb. 21-22 meeting.

Executive Summary

POLIO VACCINE SEQUENTIAL SCHEDULES WILL BE DISCUSSED BY ACIP FEB. 21-22 at a meeting of the Advisory Committee on Immunization Practices: a draft recommendation is now being written. The sequential dosing schedule being considered by ACIP is two inactivated doses administered subcutaneously at two and four months followed by two oral doses at six to 12 months and 12 to 18 months. Connaught's Ipol is the only approved IPV in the U.S.
UsernamePublicRestriction

Register

PS027604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel